Cubresa SPECT Scanner Used for Evaluation of Alzheimer’s Disease Molecular Label in vivo
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical
Webinar: Greater than the Sum
Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how one customer, Dr. Marty Pagel of the University of Arizona, is developing a dual-modality approach
Cubresa Moves to Larger Facility in Winnipeg
Cubresa’s new, larger headquarters will open for business at the following address on Tuesday September 6, 2016: Cubresa Inc. 801 Berry Street Winnipeg, MB R3H 0S7 Our telephone and facsimile numbers, as well as our e-mail addresses and web address, will remain the same. We look forward to fully utilizing our improved headquarters for research &
Preclinical PET Scanner for Simultaneous PET/MRI Installed at the University of Arizona Could Contribute to Improved Tumor Assessment
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for
BIOTIC and Cubresa continue successful partnership with PET scanner testing
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a
Cubresa Booth 207 at WMIC in New York
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)
Imaging cloak patent could enable more accurate 3D medical imaging
Winnipeg, MB – July 13, 2016 – Instead of a cloak of invisibility hiding a person in television and movies, a new method that describes mounting many imaging sensors underneath a flexible substrate could reveal tumors within humans or animals. Cubresa Inc., a medical imaging company that develops and markets nuclear imaging systems, today announced
Preclinical PET Scanner for Simultaneous PET/MRI Adds to Cancer Research Arsenal at the University of Arizona
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Cancer researchers can better understand tumors using Cubresa’s NuPET™ PET scanner with an MRI to see and measure responses
Cubresa Featured in MTS Talks Business Hub Video
A new video on the MTS Talks website features Cubresa Founder and CTO James Schallenberg and CEO George Abe describe their work at Cubresa and their experience doing business in the Manitoba work environment, the healthcare industry and within a supportive community. They also offer some advice to aspiring entrepreneurs. MTS Talks says the two leaders “pack a punch in
Cubresa Named in Globe & Mail Article on the Diverse, Strong Economy of Winnipeg
In a recent Globe & Mail article “Winnipeg: Canada’s unlikely economic sweet spot”, Cubresa is mentioned as part of an extremely diversified economy that powers the Manitoba provincial economy, an economy that no longer depends on a single natural resource. Cubresa board member, David Asper is quoted in the article. A lawyer and businessman, Asper plays a leading
NuPET™ Preclinical PET Scanner Released for Simultaneous PET/MRI in Existing MRI Systems
Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Winnipeg, MB – April 26, 2016 – A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical
WMIC 2016 Annual Congress & Exhibition
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York Come visit us in Booth 207 at the Jacob Javits Convention Center in New York, September 7 to 10, 2016. We will be showcasing our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The NuPET scanner enables simultaneous PET and MR imaging within your existing
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
Products
Clinical:
Preclinical:
Contact
Request more information